StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > delisting

<< Previous

Bullboard Posts

Next >>

Comment by WillHeyon Sep 25, 2024 12:10pm

63 Views

Post# 36240373

RE:RE:RE:RE:delisting

I doubt he used his username on stockhouse as his email to Rebecca.

Plus she would have to be smart enough to put 2 and 2 together and since 1+1 = 3 I doubt she can do that.

would be nice if they actually did some work at stagezero and got the stock out of HALTED status rather than read stockhouse.

no matter how much you pump you cannot hide the fact this company is a complete joke

<< Previous

Bullboard Posts

Next >>

AI companies to invest in